Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer.
J Immunother Cancer. 2023 Aug;11(8):e007336. doi: 10.1136/jitc-2023-007336.
J Immunother Cancer. 2023.
PMID: 37586771
Free PMC article.
Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy.
Baleeiro RB, Dunmall LSC, Liu P, Lu S, Lone Y, Lemoine NR, Wang Y.
Baleeiro RB, et al.
Front Immunol. 2022 May 26;13:902709. doi: 10.3389/fimmu.2022.902709. eCollection 2022.
Front Immunol. 2022.
PMID: 35720289
Free PMC article.
Item in Clipboard
MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy.
Baleeiro RB, Bouwens CJ, Liu P, Di Gioia C, Dunmall LSC, Nagano A, Gangeswaran R, Chelala C, Kocher HM, Lemoine NR, Wang Y.
Baleeiro RB, et al.
Oncoimmunology. 2022 May 27;11(1):2080329. doi: 10.1080/2162402X.2022.2080329. eCollection 2022.
Oncoimmunology. 2022.
PMID: 35655709
Free PMC article.
Item in Clipboard
Cite
Cite